Locating Biomarkers in OCD Through Behavioral Tasks
NCT03313622 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2025-07-20
Summary
Subjects that have a diagnosis of OCD will participate in a clinical interview and cognitive tasks, during which they will be exposed to their individual OC stressors or will be asked to make decisions related to information value and quantity while measuring neural activity and filming facial reactions. This will assist investigators to look for biomarkers of that change. This study offers a unique opportunity to develop biomarkers for key domains of OCD, and other neuropsychiatric disorders, that are grounded in brain neurocircuitry at the individual-patient level.
Subjects will participate in a clinical interview (Day 1), and then tasks+EEG (Day 2). Day 1 will be 4 hours or less, and Day 2 will be 2.5 hours or less.
Conditions
- OCD
- Obsessive-Compulsive Disorder
Interventions
- BEHAVIORAL
-
Beads Task
Participants will be asked to make a series of decisions that involve combining information about the value and probability of potential rewards. Subjects will sit in front of a computer monitor and place their hand over a box with orange and blue button that they will be asked to press based on their idea of which one will be the majority in a jar full of orange and blue beads. This task should take 15-20 minutes to complete, not including EEG setup.
- BEHAVIORAL
-
PROVOC Tasks
Three tasks will be developed collaboratively with the participant and independent evaluator that involve the participant being exposed to triggers that are considered by him/her impossible to confront without ritualizing. There will also be a similar process involving objects that should not cause any distress to be used as a control. Sessions will be videotaped with AFAR system concurrent to recording of LFPs from VS and scalp EEG.
Sponsors & Collaborators
-
Brown University
collaborator OTHER -
University of Pittsburgh
collaborator OTHER -
Butler Hospital
collaborator OTHER -
Baylor College of Medicine
lead OTHER
Principal Investigators
-
Wayne Goodman, MD · Baylor College of Medicine
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-03-31
- Primary Completion
- 2026-03-31
- Completion
- 2026-03-31
Countries
- United States
Study Locations
More Related Trials
-
Development of Adaptive Deep Brain Stimulation for OCD (Phase 1a)
NCT03457675 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Personalized Computerized Inhibitory Control Training for OCD
NCT02378896 ·Status: COMPLETED ·Phase: NA
-
Neural Predictors and Neural Changes Associated With Cognitive Behavior Therapy for Obssesive Compulsive Disorder
NCT04042038 ·Status: UNKNOWN ·Phase: NA
-
Cerebral and Cognitive Markers of Treatment Resistance in Obsessive Compulsive Disorder
NCT05843604 ·Status: RECRUITING
-
Development of an Instrument That Monitors Behaviors Associated With OCD
NCT02866422 ·Status: COMPLETED
-
Using Personalized Assessments in the Treatment of Childhood OCD
NCT06407648 ·Status: RECRUITING ·Phase: NA
-
Long-term Follow-up in Patients With Deep Brain Stimulation (DBS) for Obsessive Compulsive Disorder (OCD).
NCT01879254 ·Status: COMPLETED
-
How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD
NCT05359562 ·Status: RECRUITING ·Phase: NA
-
Modification of Cerebral Activity of Obsessive Compulsive Disorder (OCD) Patients During Cognitive and Behavioral Therapy
NCT01331876 ·Status: COMPLETED ·Phase: NA
-
Neurobehavioral Investigations of Approach Dynamics in the Ventral Striatum
NCT05422469 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Intensive Cognitive-Behavioral Therapy For Obsessive-Compulsive Disorder
NCT01368510 ·Status: COMPLETED ·Phase: NA
-
Neural Effects of Cognitive-behaviour Therapy in Panic Disorder
NCT03251235 ·Status: COMPLETED ·Phase: NA
-
DBS for Treatment-resistant Obsessive-compulsive Disorder
NCT06360991 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Exploring The Metacognitive Beliefs in OCD: A Randomized Controlled Trial of Metacognitive Therapy
NCT07052812 ·Status: COMPLETED ·Phase: NA
-
Clinical Outcomes From NOCD Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention
NCT04701372 ·Status: COMPLETED
-
Neurobiological Markers of Treatment Response for Anxiety and OCD
NCT05663489 ·Status: RECRUITING
-
Impact of COVID-19 on Mental Health of OCD Patients and live-in Family Members
NCT05656456 ·Status: COMPLETED
-
A Lifestyle Intervention to Reduce Cardiometabolic Risk Factors in Individuals With Obsessive-compulsive Disorder
NCT07206212 ·Status: RECRUITING ·Phase: NA
-
Brief Anxiety Sensitivity Treatment for Obsessive Compulsive Symptoms
NCT02635178 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Feasibility of a Personalized Treatment for Depression With Co-Occurring Anxiety
NCT00930293 ·Status: COMPLETED ·Phase: NA
-
Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder
NCT06660225 ·Status: RECRUITING ·Phase: NA
-
Deep Brain Stimulation for Obsessive Compulsive Disorder (OCD PMCF)
NCT01135745 ·Status: COMPLETED ·Phase: PHASE4
-
A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive Disorder
NCT00126282 ·Status: COMPLETED ·Phase: NA
-
Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder
NCT03511534 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Computerized Training for Individuals Diagnosed With Obsessive-Compulsive and Related Disorders
NCT03182075 ·Status: COMPLETED ·Phase: NA